Skip to main content
. 2017 Mar 10;8(19):31079–31091. doi: 10.18632/oncotarget.16076

Figure 2. CCR4 expression during melanoma progression to brain metastasis.

Figure 2

(A) Representative IHC staining with anti-CCR4 antibody for PRM, LNM and MBM specimens. Black bars indicate 100 μm. The insets show a magnification of the melanoma lesions. Black arrowheads indicate CCR4-positive melanoma cells. Yellow bars indicate 20 μm. (B) Box plot comparing H score for PRM, LNM and MBM. *P ≤ 0.05.